We are live on ! Find out more

Invesco Pharmaceuticals ETF

PJP

Market cap $547M

125.10 USD

+1.01

0.81%

At close Updated Sep 14, 3:17 PM EDT

1 day

0.81%

5 days

-2.07%

1 month

-0.21%

3 months

10.69%

6 months

21.67%

Year to date

19.84%

1 year

37.61%

5 years

58.47%

10 years

93.12%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 27.8%

Neutral 61.1%

Negative 11.1%

Zacks Investment Research

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

Launched on June 23, 2005, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity market.

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

The Motley Fool

FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?

Fidelity MSCI Health Care Index ETF (FHLC) offers a significantly lower expense ratio and a higher dividend yield than the Invesco Pharmaceuticals ETF (PJP). PJP provides a concentrated portfolio of just over 30 pharmaceutical stocks, while FHLC diversifies across more than 300 holdings.

FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?

The Motley Fool

XPH vs PJP: Which Pharma ETF Offers Better Value

The State Street SPDR S&P Pharmaceuticals ETF offers a significantly lower expense ratio of 0.35% compared to the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF provides a more concentrated portfolio of 29 stocks and lower price volatility as measured by beta.

XPH vs PJP: Which Pharma ETF Offers Better Value

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Nikkei 225, Kospi jolt Asian markets as AI rout and Fed fears collide

Asian stocks were mixed on Thursday as investors assessed the fallout from the AI sell-off, the Federal Reserve's rate outlook and renewed tensions in the Middle East. The MSCI Asia-Pacific gauge excluding Japan was little changed after swinging between gains and losses.

Nikkei 225, Kospi jolt Asian markets as AI rout and Fed fears collide

Zacks Investment Research

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

Launched on 06/23/2005, the Invesco Pharmaceuticals ETF (PJP) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

The Motley Fool

As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026?

Vanguard Health Care ETF offers a lower expense ratio and higher dividend yield than Invesco Pharmaceuticals ETF Invesco Pharmaceuticals ETF has concentrated its portfolio in 29 pharmaceutical stocks whereas Vanguard Health Care ETF holds 411 healthcare companies Invesco Pharmaceuticals ETF significantly outperformed on a 1-year total return basis

As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026?

Kospi jumps 6% as Asia's battered semiconductor trade rebounds

Asian stocks rallied on Wednesday as investors returned to semiconductor shares after a bruising sell-off, taking their cue from a Wall Street rebound even as Brent crude pushed further above $91 a barrel. MSCI's Asia-Pacific gauge outside Japan gained 1.2%, while South Korea's Kospi surged more than 6% and Japan's Nikkei 225 climbed 1.9%.

Kospi jumps 6% as Asia's battered semiconductor trade rebounds

The Motley Fool

Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?

iShares Global Healthcare ETF offers broader diversification with 110 global holdings compared to 29 U.S. stocks for Invesco Pharmaceuticals ETF Invesco Pharmaceuticals ETF has a higher expense ratio of 0.57% but outperformed over the past year with a 44.90% total return iShares Global Healthcare ETF provides a higher trailing-12-month dividend yield of 1.50% while charging a lower expense ratio than its peer

Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?

The Motley Fool

PJP vs. IYH: Which Healthcare ETF Is the Better Buy?

The iShares U.S. Healthcare ETF (IYH) offers a broader portfolio with a lower expense ratio than the Invesco Pharmaceuticals ETF (PJP). PJP has delivered significantly higher total returns over the past year.

PJP vs. IYH: Which Healthcare ETF Is the Better Buy?

See News Rankings

Price charts implemented using Lightweight Charts™